![](https://endpts.com/wp-content/uploads/2020/12/Carl-Hansen-AbCellera-tile-scaled.jpg)
Carl Hansen, AbCellera CEO
Looking for the next mRNA breakthrough, Moderna taps AbCellera in mysterious antibody discovery deal
Moderna’s success with its Covid-19 vaccine has busted the dam open on a range of potential mRNA therapeutics — and now the biotech is pushing to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.